Sclerostin Inhibitors
- Name
- Sclerostin Inhibitors
- Accession Number
- DBCAT005700
- Description
Not Available
- Drugs
Drug Drug Description Romosozumab A monoclonal antibody used to treat osteoporosis in postmenopausal women at high risk of fracture, patients who are intolerant of other treatments, or patients who have failed other treatments. - Drugs & Drug Targets
Drug Target Type Romosozumab Sclerostin target